share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Nov 5 05:44

Summary by Moomoo AI

Arcutis Biotherapeutics, Inc. officer Todd Franklin Watanabe is set to sell 13,871 shares of common stock on November 4, 2024. The shares, valued at an aggregate market value of $120,459, were acquired by Watanabe on November 1, 2024, through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a period where no other securities were sold by Watanabe in the past three months, as per the provided transaction history.
Arcutis Biotherapeutics, Inc. officer Todd Franklin Watanabe is set to sell 13,871 shares of common stock on November 4, 2024. The shares, valued at an aggregate market value of $120,459, were acquired by Watanabe on November 1, 2024, through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a period where no other securities were sold by Watanabe in the past three months, as per the provided transaction history.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated